New Order keyboardist Gillian Gilbert has clarified that she is living with cancer and undergoing treatment, correcting a widespread public misunderstanding that arose following a recent interview given by her husband, bandmate, and drummer Stephen Morris to Rolling Stone.
The Bottom Line
- The Correction: Gillian Gilbert stepped forward via a Facebook statement to clarify that she, rather than husband Stephen Morris, is currently undergoing treatment for cancer.
- The Origin: The confusion began earlier this month when Morris told Rolling Stone he faced a “pretty serious” health problem preventing him from leaving the country.
- Tour Impact: The couple previously announced they would step away from New Order touring for the foreseeable future back in June, casting uncertainty on upcoming appearances.
Untangling the Interview That Sparked Concern
Morris noted he was dealing with a “pretty serious” health issue that precluded him from leaving the country for any length of time.
Here is the kicker: the narrative was entirely upside down. According to a clarifying statement published on the band’s official Facebook page under the title “A MESSAGE FROM GILLIAN,” it is the 65-year-old keyboardist herself navigating the diagnosis. Gilbert wrote that she wanted to “gently clarify a misunderstanding from the interview, in the course of which comments were misinterpreted leading people to believe that Stephen is seriously ill. Thankfully, he is well. It is in fact me, who like many other people, is living with cancer.”
Touring Plans and Hall of Fame Uncertainty
The health update brings renewed focus to New Order’s operational future. Back in June, Morris announced that both he and Gilbert would step away from the live circuit “for the foreseeable future” due to personal health reasons. While Morris recently expressed uncertainty about when or if he might rejoin the band on the road—noting to Rolling Stone that his situation involved an illness where “it’s not something that someone’s going to come up with a cure for”—the immediate priority remains Gilbert’s ongoing medical care.
Logistical questions now loom over the band’s calendar. New Order and Joy Division are scheduled for induction into the Rock & Roll Hall of Fame in Los Angeles on November 14th, though it remains unclear whether Morris will be in attendance. What is certain is that both Morris and Gilbert will be absent from New Order’s upcoming South American tour dates later this year.
| Event / Milestone | Status | Details |
|---|---|---|
| Live Touring | Stepped Away | Morris and Gilbert withdrew from touring indefinitely as of June. |
| South American Tour | Absent | Both musicians will miss the upcoming dates later this year. |
| Rock & Roll Hall of Fame Induction | Unconfirmed | Scheduled for November 14th in Los Angeles; attendance unverified. |
Community Support and the Path Forward
Gilbert expressed gratitude for the outpourings of goodwill, noting in her statement, “We have both been incredibly touched by all the kind words and well wishes… We are enormously grateful for everyone’s kindness and support and would appreciate some privacy as I continue with my treatment.”
As the band navigates this transitional chapter, the focus shifts entirely away from release schedules and stage lights toward privacy and health. Drop your thoughts and well wishes for Gillian and the band in the comments below.
Worth a look
- Will AI Replace Actors? Meeting the World’s First AI Actor, Tilly Norwood
- Macklemore Dropped from Ed Sheeran Tour Over Pro-Palestine Remarks
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)
